From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes a recent transition to being an approved/specified/listed/etc. choice inside buyers' systems, such that future business can arrive without discrete selling, and that this is new and the volume is ahead. Scan the transcript for relevant statements. Management discusses progress, contracts, subscriptions, partnerships, but does it mention being placed on approved vendor lists, specifications, etc.? They mention "we are in discussions with several companies outside the rail industry" and "we are progressing in talks to build the first of several Duos-owned portals" but that's not about being listed. They mention "our technology conducted scans on more than 8.5 million railcars" but that's operational. They mention "we have also demonstrated our technology to the Customs and Border Patrol Agency" but that's not a listing. They mention "we are in discussions with several large telecommunications companies" but that's not a listing. They mention "we have identified or are in discussions with several large telecommunications companies to deploy its data centers" - again not a listing. The key phrase: "we are in discussions" or "we are progressing" indicates pending, not achieved. They also mention "we have also made progress in shifting our revenue model to become more software, artificial intelligence, and services focused. Our recently signed deals with two major railroads for AI subscription and support services contracts is just the beginning." That's about signed deals, not about being placed on a list. They mention "we are engaged in more than $100 million of opportunities" but that's opportunities, not approved status. No mention of being added to a specification, approved vendor list, formulary, etc. The closest is "we have also demonstrated our technology to the Customs and Border Patrol Agency" but that's just a demo. They mention "we have shown the technology to a significant number of car manufacturers" but that's not a listing. Thus, no evidence of the described phenomenon. Answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.